MORGAN FINDLAY: Open Payments
NPI 1063097798 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 22 payments from 8 companies in 2025. Trend: 2023 $861 · 2024 $489 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $258 |
| E.R. Squibb & Sons, L.L.C. | 5 | $139 |
| UCB, Inc. | 2 | $61 |
| Organon LLC | 5 | $46 |
| Lilly USA, LLC | 2 | $35 |
| TAIHO ONCOLOGY, INC. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $13 |
Products named: TREMFYA, Sotyktu, Bimzelx, TALTZ, LONSURF, DUPIXENT, Winlevi.
Industry payments across CA — which companies pay providers there.
